ALT 0 3 0 3 B-clinical_variable
< 4 5 4 5 O
2 6 7 6 7 B-upper_bound
times 8 13 8 13 I-upper_bound
ULN 14 17 14 17 I-upper_bound

Able 0 4 18 22 O
( 5 6 23 24 O
i.e. 6 10 24 28 O
, 10 11 28 29 O
sufficiently 12 24 30 42 O
fluent 25 31 43 49 B-language_fluency
in 32 34 50 52 I-language_fluency
English 35 42 53 60 I-language_fluency
or 43 45 61 63 I-language_fluency
French 46 52 64 70 I-language_fluency
) 52 53 70 71 O
and 54 57 72 75 O
willing 58 65 76 83 O
to 66 68 84 86 O
complete 69 77 87 95 O
the 78 81 96 99 O
patient 82 89 100 107 O
- 89 90 107 108 O
reported 90 98 108 116 O
outcome 99 106 117 124 O
questionnaires 107 121 125 139 O
, 121 122 139 140 O
social 123 129 141 147 O
determinants 130 142 148 160 O
of 143 145 161 163 O
exercise 146 154 164 172 O
measurement 155 166 173 184 O
, 166 167 184 185 O
health 168 174 186 192 O
economics 175 184 193 202 O
, 184 185 202 203 O
and 186 189 204 207 O
physical 190 198 208 216 O
activity 199 207 217 225 O
questionnaires 208 222 226 240 O
and 223 226 241 244 O
logs 227 231 245 249 O

Able 0 4 250 254 O
( 5 6 255 256 O
i.e. 6 10 256 260 O
, 10 11 260 261 O
sufficiently 12 24 262 274 O
fluent 25 31 275 281 O
) 31 32 281 282 O
and 33 36 283 286 O
willing 37 44 287 294 O
to 45 47 295 297 O
effectively 48 59 298 309 O
communicate 60 71 310 321 O
with 72 76 322 326 O
the 77 80 327 330 O
physical 81 89 331 339 O
activity 90 98 340 348 O
consultant 99 109 349 359 O
affiliated 110 120 360 370 O
with 121 125 371 375 O
the 126 129 376 379 O
originating 130 141 380 391 O
cancer 142 148 392 398 B-cancer
center 149 155 399 405 O

Absolute 0 8 406 414 B-clinical_variable
granulocyte 9 20 415 426 I-clinical_variable
count 21 26 427 432 I-clinical_variable
≥ 27 28 433 434 O
1,000 29 34 435 440 B-lower_bound
/ 34 35 440 441 I-lower_bound
mm³ 35 38 441 444 I-lower_bound

Adjuvant 0 8 445 453 B-treatment
chemotherapy 9 21 454 466 I-treatment
treatment 22 31 467 476 I-treatment
for 32 35 477 480 O
colon 36 41 481 486 B-cancer
cancer 42 48 487 493 I-cancer
with 49 53 494 498 O
a 54 55 499 500 O
5 56 57 501 502 B-treatment
- 57 58 502 503 I-treatment
fluorouracil- 58 71 503 516 I-treatment
based 72 77 517 522 I-treatment
regimen 78 85 523 530 I-treatment
received 86 94 531 539 O
with 95 99 540 544 O
an 100 102 545 547 O
intent 103 109 548 554 O
to 110 112 555 557 O
provide 113 120 558 565 O
a 121 122 566 567 O
complete 123 131 568 576 O
course 132 138 577 583 O
of 139 141 584 586 O
treatment 142 151 587 596 O

Alkaline 0 8 597 605 B-clinical_variable
phosphatase 9 20 606 617 I-clinical_variable
< 21 22 618 619 O
2.5 23 26 620 623 B-upper_bound
times 27 32 624 629 I-upper_bound
ULN 33 36 630 633 B-clinical_variable

Carcinoembryonic 0 16 634 650 B-clinical_variable
antigen 17 24 651 658 I-clinical_variable
( 25 26 659 660 I-clinical_variable
CEA 26 29 660 663 I-clinical_variable
) 29 30 663 664 I-clinical_variable
≤ 31 32 665 666 O
5 33 34 667 668 B-upper_bound
μg 35 37 669 671 I-upper_bound
/ 37 38 671 672 I-upper_bound
L 38 39 672 673 I-upper_bound

Chemotherapy 0 12 674 686 B-treatment
must 13 17 687 691 O
have 18 22 692 696 O
been 23 27 697 701 O
completed 28 37 702 711 O
( 38 39 712 713 O
i.e. 39 43 713 717 O
last 44 48 718 722 O
dose 49 53 723 727 O
received 54 62 728 736 O
) 62 63 736 737 O
a 64 65 738 739 O
minimum 66 73 740 747 O
of 74 76 748 750 O
60 77 79 751 753 B-lower_bound
days 80 84 754 758 I-lower_bound
and 85 88 759 762 O
a 89 90 763 764 O
maximum 91 98 765 772 O
of 99 101 773 775 O
180 102 105 776 779 B-upper_bound
days 106 110 780 784 I-upper_bound
prior 111 116 785 790 I-upper_bound
to 117 119 791 793 O
registration 120 132 794 806 O

Completely 0 10 807 817 O
resected 11 19 818 826 O
histologically 20 34 827 841 O
confirmed 35 44 842 851 O
adenocarcinoma 45 59 852 866 B-cancer
of 60 62 867 869 I-cancer
the 63 66 870 873 I-cancer
colon 67 72 874 879 I-cancer

Completion 0 10 880 890 O
of 11 13 891 893 O
chest 14 19 894 899 B-treatment
x 20 21 900 901 I-treatment
- 21 22 901 902 I-treatment
ray 22 25 902 905 I-treatment
or 26 28 906 908 O
CT 29 31 909 911 B-treatment
, 31 32 911 912 O
and 33 36 913 916 O
CT 37 39 917 919 O
, 39 40 919 920 O
MRI 41 44 921 924 B-treatment
or 45 47 925 927 O
ultrasound 48 58 928 938 B-treatment
of 59 61 939 941 I-treatment
abdomen 62 69 942 949 I-treatment
within 70 76 950 956 O
60 77 79 957 959 B-upper_bound
days 80 84 960 964 I-upper_bound
of 85 87 965 967 O
registration 88 100 968 980 O
; 100 101 980 981 O
these 102 107 982 987 O
imaging 108 115 988 995 O
tests 116 121 996 1001 O
must 122 126 1002 1006 O
not 127 130 1007 1010 O
show 131 135 1011 1015 O
evidence 136 144 1016 1024 O
of 145 147 1025 1027 O
metastatic 148 158 1028 1038 B-cancer
or 159 161 1039 1041 O
locally 162 169 1042 1049 O
- 169 170 1049 1050 O
recurrent 170 179 1050 1059 O
colon 180 185 1060 1065 B-cancer
cancer 186 192 1066 1072 I-cancer

Current 0 7 1073 1080 O
physical 8 16 1081 1089 O
activity 17 25 1090 1098 O
levels 26 32 1099 1105 O
do 33 35 1106 1108 O
not 36 39 1109 1112 O
meet 40 44 1113 1117 O
the 45 48 1118 1121 O
recommended 49 60 1122 1133 O
guidelines 61 71 1134 1144 O
( 72 73 1145 1146 O
≥ 73 74 1146 1147 O
150 75 78 1148 1151 B-lower_bound
minutes 79 86 1152 1159 I-lower_bound
of 87 89 1160 1162 O
moderate 90 98 1163 1171 O
- 98 99 1171 1172 O
to 99 101 1172 1174 O
- 101 102 1174 1175 O
vigorous 102 110 1175 1183 O
or 111 113 1184 1186 O
≥ 114 115 1187 1188 O
75 116 118 1189 1191 B-lower_bound
minutes 119 126 1192 1199 I-lower_bound
of 127 129 1200 1202 O
vigorous 130 138 1203 1211 O
physical 139 147 1212 1220 O
activity 148 156 1221 1229 O
/ 156 157 1229 1230 O
week 157 161 1230 1234 O
) 161 162 1234 1235 O
as 163 165 1236 1238 O
calculated 166 176 1239 1249 O
using 177 182 1250 1255 O
the 183 186 1256 1259 O
Leisure 187 194 1260 1267 B-clinical_variable
Time 195 199 1268 1272 I-clinical_variable
Exercise 200 208 1273 1281 I-clinical_variable
Questionnaire 209 222 1282 1295 I-clinical_variable
( 223 224 1296 1297 I-clinical_variable
LTEQ 224 228 1297 1301 I-clinical_variable
) 228 229 1301 1302 I-clinical_variable

ECOG 0 4 1303 1307 B-clinical_variable
performance 5 16 1308 1319 I-clinical_variable
status 17 23 1320 1326 I-clinical_variable
0 24 25 1327 1328 B-lower_bound
- 25 26 1328 1329 O
1 26 27 1329 1330 B-upper_bound

Hemoglobin 0 10 1331 1341 B-clinical_variable
≥ 11 12 1342 1343 O
100 13 16 1344 1347 B-lower_bound
g 17 18 1348 1349 I-lower_bound
/ 18 19 1349 1350 I-lower_bound
L 19 20 1350 1351 I-lower_bound

Less 0 4 1352 1356 O
than 5 9 1357 1361 O
12 10 12 1362 1364 B-upper_bound
sampled 13 20 1365 1372 O
lymph 21 26 1373 1378 B-chronic_disease
nodes 27 32 1379 1384 I-chronic_disease

No 0 2 1385 1387 O
concurrent 3 13 1388 1398 B-treatment
anticancer 14 24 1399 1409 I-treatment
treatment 25 34 1410 1419 I-treatment
including 35 44 1420 1429 O
chemotherapy 45 57 1430 1442 B-treatment
, 57 58 1442 1443 O
biological 59 69 1444 1454 B-treatment
, 69 70 1454 1455 O
or 71 73 1456 1458 O
targeted 74 82 1459 1467 B-treatment
agents 83 89 1468 1474 I-treatment

No 0 2 1475 1477 O
concurrent 3 13 1478 1488 O
treatment 14 23 1489 1498 B-treatment
with 24 28 1499 1503 O
additional 29 39 1504 1514 O
chemotherapy 40 52 1515 1527 B-treatment
or 53 55 1528 1530 O
radiation 56 65 1531 1540 B-treatment

No 0 2 1541 1543 O
concurrent 3 13 1544 1554 O
treatment 14 23 1555 1564 B-treatment
with 24 28 1565 1569 O
any 29 32 1570 1573 O
medications 33 44 1574 1585 B-treatment
deemed 45 51 1586 1592 O
by 52 54 1593 1595 O
the 55 58 1596 1599 O
investigator 59 71 1600 1612 O
as 72 74 1613 1615 O
likely 75 81 1616 1622 O
to 82 84 1623 1625 O
preclude 85 93 1626 1634 O
participation 94 107 1635 1648 O
in 108 110 1649 1651 O
a 111 112 1652 1653 O
physical 113 121 1654 1662 O
activity 122 130 1663 1671 O
program 131 138 1672 1679 O

No 0 2 1680 1682 O
history 3 10 1683 1690 O
of 11 13 1691 1693 O
other 14 19 1694 1699 O
malignancies 20 32 1700 1712 B-cancer

No 0 2 1713 1715 O
prior 3 8 1716 1721 O
radiotherapy 9 21 1722 1734 B-treatment
as 22 24 1735 1737 O
a 25 26 1738 1739 O
component 27 36 1740 1749 O
of 37 39 1750 1752 O
treatment 40 49 1753 1762 B-treatment
for 50 53 1763 1766 O
primary 54 61 1767 1774 B-cancer
tumor 62 67 1775 1780 I-cancer

No 0 2 1781 1783 O
rectal 3 9 1784 1790 B-cancer
cancer 10 16 1791 1797 I-cancer

Not 0 3 1798 1801 B-pregnancy
pregnant 4 12 1802 1810 I-pregnancy
or 13 15 1811 1813 O
planning 16 24 1814 1822 B-pregnancy
to 25 27 1823 1825 I-pregnancy
become 28 34 1826 1832 I-pregnancy
pregnant 35 43 1833 1841 I-pregnancy
within 44 50 1842 1848 O
the 51 54 1849 1852 O
next 55 59 1853 1857 B-upper_bound
3 60 61 1858 1859 I-upper_bound
years 62 67 1860 1865 I-upper_bound

Platelet 0 8 1866 1874 B-clinical_variable
count 9 14 1875 1880 I-clinical_variable
≥ 15 16 1881 1882 O
100,000 17 24 1883 1890 B-lower_bound
/ 24 25 1890 1891 I-lower_bound
mm³ 25 28 1891 1894 I-lower_bound

Serum 0 5 1895 1900 B-clinical_variable
creatinine 6 16 1901 1911 I-clinical_variable
≤ 17 18 1912 1913 O
1.5 19 22 1914 1917 B-upper_bound
times 23 28 1918 1923 O
upper 29 34 1924 1929 B-clinical_variable
limit 35 40 1930 1935 I-clinical_variable
of 41 43 1936 1938 I-clinical_variable
normal 44 50 1939 1945 I-clinical_variable
( 51 52 1946 1947 I-clinical_variable
ULN 52 55 1947 1950 I-clinical_variable
) 55 56 1950 1951 I-clinical_variable

Stage 0 5 1952 1957 O
III 6 9 1958 1961 O
disease 10 17 1962 1969 O
, 17 18 1969 1970 O
defined 19 26 1971 1978 O
as 27 29 1979 1981 O
having 30 36 1982 1988 O
at 37 39 1989 1991 O
least 40 45 1992 1997 O
one 46 49 1998 2001 B-lower_bound
pathologically 50 64 2002 2016 O
confirmed 65 74 2017 2026 O
positive 75 83 2027 2035 O
lymph 84 89 2036 2041 B-clinical_variable
node 90 94 2042 2046 I-clinical_variable
or 95 97 2047 2049 O
one 98 101 2050 2053 O
pathologically 102 116 2054 2068 O
confirmed 117 126 2069 2078 O
positive 127 135 2079 2087 O
tumour 136 142 2088 2094 B-cancer
deposit 143 150 2095 2102 O

Synchronous 0 11 2103 2114 O
primary 12 19 2115 2122 O
colon 20 25 2123 2128 B-cancer
cancer 26 32 2129 2135 I-cancer

T4 0 2 2136 2138 B-cancer
lesions 3 10 2139 2146 I-cancer

Total 0 5 2147 2152 O
bilirubin 6 15 2153 2162 B-clinical_variable
≤ 16 17 2163 2164 O
1.5 18 21 2165 2168 B-upper_bound
times 22 27 2169 2174 I-upper_bound
upper 28 33 2175 2180 I-upper_bound
limit 34 39 2181 2186 I-upper_bound
of 40 42 2187 2189 I-upper_bound
normal 43 49 2190 2196 I-upper_bound
( 50 51 2197 2198 I-upper_bound
ULN 51 54 2198 2201 I-upper_bound
) 54 55 2201 2202 I-upper_bound

adequately 0 10 2203 2213 O
treated 11 18 2214 2221 O
nonmelanoma 19 30 2222 2233 B-cancer
skin 31 35 2234 2238 I-cancer
cancer 36 42 2239 2245 I-cancer
, 42 43 2245 2246 O
curatively 44 54 2247 2257 O
treated 55 62 2258 2265 O
in 63 65 2266 2268 B-cancer
situ 66 70 2269 2273 I-cancer
cancer 71 77 2274 2280 I-cancer
of 78 80 2281 2283 O
the 81 84 2284 2287 O
cervix 85 91 2288 2294 O
, 91 92 2294 2295 O
other 93 98 2296 2301 O
solid 99 104 2302 2307 B-cancer
tumors 105 111 2308 2314 I-cancer
, 111 112 2314 2315 O
Hodgkin 113 120 2316 2323 B-cancer
lymphoma 121 129 2324 2332 I-cancer
, 129 130 2332 2333 O
or 131 133 2334 2336 O
non 134 137 2337 2340 B-cancer
- 137 138 2340 2341 I-cancer
Hodgkin 138 145 2341 2348 I-cancer
lymphoma 146 154 2349 2357 I-cancer
curatively 155 165 2358 2368 O
treated 166 173 2369 2376 O
with 174 178 2377 2381 O
no 179 181 2382 2384 O
evidence 182 190 2385 2393 O
of 191 193 2394 2396 O
disease 194 201 2397 2404 O
for 202 205 2405 2408 O
> 206 207 2409 2410 O
5 208 209 2411 2412 B-lower_bound
years 210 215 2413 2418 I-lower_bound

participants 0 12 2419 2431 O
must 13 17 2432 2436 O
have 18 22 2437 2441 O
received 23 31 2442 2450 O
a 32 33 2451 2452 O
minimum 34 41 2453 2460 O
of 42 44 2461 2463 O
one 45 48 2464 2467 B-lower_bound
treatment 49 58 2468 2477 O
cycle 59 64 2478 2483 O

patients 0 8 2484 2492 O
who 9 12 2493 2496 O
are 13 16 2497 2500 O
pre 17 20 2501 2504 O
- 20 21 2504 2505 O
planned 21 28 2505 2512 O
to 29 31 2513 2515 O
receive 32 39 2516 2523 O
a 40 41 2524 2525 O
shorter 42 49 2526 2533 O
duration 50 58 2534 2542 O
of 59 61 2543 2545 O
chemotherapy 62 74 2546 2558 B-treatment
, 74 75 2558 2559 O
including 76 85 2560 2569 O
as 86 88 2570 2572 O
part 89 93 2573 2577 O
of 94 96 2578 2580 O
a 97 98 2581 2582 O
research 99 107 2583 2591 O
study 108 113 2592 2597 O

